Who Owns Verrica Pharmaceuticals Stock?
NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:00 PM ET
Ownership breakdown
- Held by institutions
- 27.14%
- Held by insiders
- 49.00%
- Institutional holders
- 48
- Institutions 27.1%
- Insiders 49.0%
- Public and other 23.9%
Who owns Verrica Pharmaceuticals stock?
Institutional investors own about 27.1% of Verrica Pharmaceuticals's shares, spread across 48 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 49.00% of VRCA.
The largest institutional holders are Caligan Partners, LP (5.38%), Cannell Capital LLC (4.56%) and Affinity Asset Advisors, Llc (4.12%). Together, the top 10 institutions control 25.0% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their VRCA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VRCA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Caligan Partners, LP | 923.91K | 5.38% | 0.0% |
| Cannell Capital LLC | 783.92K | 4.56% | +14.4% |
| Affinity Asset Advisors, Llc | 707.34K | 4.12% | 0.0% |
| Velan Capital Investment Management LP | 471.56K | 2.75% | 0.0% |
| Armistice Capital, LLC | 426.30K | 2.48% | -17.7% |
| Boothbay Fund Management, LLC | 280.73K | 1.63% | 0.0% |
| Vanguard Capital Management LLC | 279.31K | 1.63% | +48.0% |
| Mariner, LLC | 207.23K | 1.21% | +744.3% |
| Geode Capital Management, LLC | 138.16K | 0.80% | -0.5% |
| Blackrock Inc. | 74.34K | 0.43% | +92.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VRCA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 143.14K | 0.83% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 135.47K | 0.79% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 60.99K | 0.36% |
| iShares Trust-iShares Micro-Cap ETF | 36.01K | 0.21% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 20.50K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 18.97K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 12.26K | 0.07% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 7.37K | 0.04% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 2.19K | 0.01% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 2.09K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Verrica Pharmaceuticals?
Caligan Partners, LP is the largest institutional shareholder of VRCA, owning 5.38% of shares outstanding (923.91K shares) as of its latest 13F filing.
What percentage of Verrica Pharmaceuticals is owned by institutions?
Institutions own about 27.1% of VRCA shares and 53.2% of the public float.
How much of Verrica Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 49.00% of VRCA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.